William Blair & Company’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$112M Sell
1,665,665
-261,722
-14% -$17.4M 0.29% 80
2026
Q1
$121M Sell
1,927,387
-61,454
-3% -$4.28M 0.35% 66
2025
Q4
$132M Sell
1,988,841
-120,502
-6% -$7.79M 0.35% 65
2025
Q3
$142M Sell
2,109,343
-98,701
-4% -$7.81M 0.38% 68
2025
Q2
$193M Sell
2,208,044
-30,519
-1% -$2.39M 0.54% 51
2025
Q1
$153M Buy
2,238,563
+5,916
+0.3% +$483K 0.46% 58
2024
Q4
$174M Sell
2,232,647
-509,462
-19% -$37.7M 0.51% 55
2024
Q3
$184M Sell
2,742,109
-1,557,310
-36% -$128M 0.54% 52
2024
Q2
$487M Sell
4,299,419
-233,268
-5% -$29.5M 1.5% 8
2024
Q1
$629M Buy
4,532,687
+64,683
+1% +$8.13M 1.97% 5
2023
Q4
$554M Sell
4,468,004
-39,149
-0.9% -$4M 1.89% 6
2023
Q3
$421M Buy
4,507,153
+73,654
+2% +$8.3M 1.61% 9
2023
Q2
$570M Buy
4,433,499
+77,048
+2% +$9.32M 2.09% 5
2023
Q1
$506M Sell
4,356,451
-64,976
-1% -$7.27M 2.02% 5
2022
Q4
$501M Sell
4,421,427
-200,321
-4% -$22M 2.18% 3
2022
Q3
$372M Buy
4,621,748
+119,780
+3% +$10.1M 1.71% 8
2022
Q2
$336M Sell
4,501,968
-138,812
-3% -$12.7M 1.49% 10
2022
Q1
$594M Sell
4,640,780
-77,848
-2% -$8.52M 2.08% 5
2021
Q4
$633M Sell
4,718,628
-93,680
-2% -$13.5M 1.99% 5
2021
Q3
$658M Sell
4,812,308
-14,820
-0.3% -$1.87M 2.24% 5
2021
Q2
$515M Buy
4,827,128
+80,476
+2% +$7.73M 1.79% 8
2021
Q1
$426M Buy
4,746,652
+419,488
+10% +$39.4M 1.61% 8
2020
Q4
$400M Buy
4,327,164
+140,576
+3% +$12.6M 1.47% 12
2020
Q3
$431M Sell
4,186,588
-107,468
-3% -$11.2M 1.83% 8
2020
Q2
$435M Sell
4,294,056
-247,304
-5% -$22.1M 2.08% 7
2020
Q1
$306M Sell
4,541,360
-278,996
-6% -$17.4M 1.91% 7
2019
Q4
$264M Buy
4,820,356
+225,408
+5% +$10.7M 1.35% 12
2019
Q3
$171M Buy
4,594,948
+43,284
+1% +$1.68M 0.99% 18
2019
Q2
$171M Buy
4,551,664
+510,244
+13% +$16M 0.97% 19
2019
Q1
$120M Buy
4,041,420
+179,212
+5% +$6.3M 0.73% 27
2018
Q4
$116M Sell
3,862,208
-73,400
-2% -$2.33M 0.84% 24
2018
Q3
$141M Sell
3,935,608
-78,804
-2% -$2.44M 0.86% 22
2018
Q2
$95.3M Buy
4,014,412
+178,148
+5% +$3.78M 0.65% 39
2018
Q1
$71.1M Sell
3,836,264
-275,904
-7% -$4.08M 0.5% 50
2017
Q4
$59M Sell
4,112,168
-361,056
-8% -$4.69M 0.4% 61
2017
Q3
$54.7M Buy
4,473,224
+37,668
+0.8% +$666K 0.41% 64
2017
Q2
$81.1M Buy
4,435,556
+396,356
+10% +$7.32M 0.61% 38
2017
Q1
$81M Buy
4,039,200
+75,676
+2% +$1.48M 0.65% 35
2016
Q4
$59.2M Sell
3,963,524
-560,432
-12% -$9.93M 0.53% 52
2016
Q3
$99.1M Buy
4,523,956
+122,952
+3% +$2.74M 0.88% 19
2016
Q2
$87.3M Sell
4,401,004
-135,056
-3% -$2.3M 0.81% 23
2016
Q1
$77M Buy
4,536,060
+195,476
+5% +$3.27M 0.73% 29
2015
Q4
$88.9M Buy
4,340,584
+266,644
+7% +$5.55M 0.83% 20
2015
Q3
$87.4M Sell
4,073,940
-226,308
-5% -$5.05M 0.76% 23
2015
Q2
$86M Buy
4,300,248
+43,512
+1% +$764K 0.13% 210
2015
Q1
$66.3M Sell
4,256,736
-324,480
-7% -$4.9M 0.1% 266
2014
Q4
$63M Sell
4,581,216
-95,564
-2% -$1.17M 0.1% 272
2014
Q3
$46.8M Buy
4,676,780
+1,972,936
+73% +$20.2M 0.08% 327
2014
Q2
$26.8M Sell
2,703,844
-82,912
-3% -$735K 0.04% 471
2014
Q1
$28.8M Sell
2,786,756
-293,516
-10% -$3.03M 0.05% 450
2013
Q4
$27.3M Sell
3,080,272
-233,340
-7% -$1.85M 0.05% 468
2013
Q3
$23.4M Sell
3,313,612
-72,460
-2% -$459K 0.04% 484
2013
Q2
$19M Buy
+3,386,072
New +$16.2M 0.04% 496

Other funds holding DXCM

William Blair & Company's DXCM Position: Q2 2026 in Review

William Blair & Company reduced its DexCom (DXCM) stake by 14% in Q2 2026, selling an estimated $17.4M and leaving 1,665,665 shares worth $112M. The position accounts for 0.29% of the portfolio, ranked #80.

William Blair & Company first reported a position in DXCM in Q2 2013 and has held it in 53 quarters since. The position peaked at $658M in Q3 2021. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • William Blair & Company held 1,665,665 shares of DexCom worth $112M as of Q2 2026.
  • William Blair & Company sold 261,722 DexCom shares in Q2 2026, an estimated $17.4M.
  • DexCom made up 0.29% of William Blair & Company's portfolio in Q2 2026, its #80 holding.
  • William Blair & Company first reported a position in DexCom in Q2 2013 and has held it in 53 quarters since.
  • William Blair & Company's DexCom position peaked at $658M in Q3 2021.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.